Subscribe To
How behind-the-scenes medpace navigated a biotech slump to hit a record high
Medpace continues navigating a tricky biotech space fraught with funding challenges. MEDP stock is near...
December 28, 2022, 8:00 am
Aptose biosciences to present at biotech showcase™ 2023 conference
SAN DIEGO and TORONTO, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company...
December 28, 2022, 7:30 am
Adaptive biotechnologies to present at the 41st annual j.p. morgan healthcare conference
SEATTLE, Dec. 27, 2022 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage b...
December 27, 2022, 9:05 pm
Jefferies analyst reveals his top two biotech stocks for 2023
Moderna Inc (NASDAQ: MRNA) has tanked nearly 15% in recent days but a Jefferies analyst dubs it one of his best ideas for 2023. Moderna stock could cl...
December 27, 2022, 7:26 pm
Jefferies' michael yee still likes amgen in the biotech sector
Michael Yee, Jefferies biotech analyst, joins 'Closing Bell' to discuss biotech, which is on pace for i...
December 27, 2022, 4:35 pm
Adaptive biotechnologies to present at the 41st annual j.p. morgan healthcare conference
SEATTLE, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage bi...
December 27, 2022, 4:05 pm
4 top biotech stocks worth adding to your portfolio in 2023
New drug approvals and focus on coronavirus treatments should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and...
December 27, 2022, 12:47 pm
Capture the growth potential in china's biotech sector with this etf
With China's economy recovering from a real estate development crisis and rising COVID-19 cases in 2022, it only sets up growth potential for 2023. On...
December 27, 2022, 12:14 pm
Should you invest in the invesco dynamic biotechnology & genome etf (pbe)?
Sector ETF report for PBE...
December 27, 2022, 7:31 am
Is vertex pharmaceuticals a buy?
There's more growth ahead for this biotech giant....
December 27, 2022, 6:15 am
Top-read disruptive technology stories of 2022
2022 has been a wild year for markets, from Russia's invasion of Ukraine to the Fed's dedicated rate hike campaign. That hasn't stopped the world from...
December 26, 2022, 3:44 pm
This stock just soared by 20%: should you buy now?
It's been an otherwise poor year for this biotech on the stock market....
December 26, 2022, 8:30 am
2 top biotech stocks to buy for the long haul
These mid-cap biotechs are solid long-term choices....
December 25, 2022, 8:30 am
Three pharma stocks to sell before they die
As we head into New Year 2023, we wanted to take a look at some of the top biotech blunders of the last...
December 24, 2022, 5:20 pm
3 under-the-radar biotech stocks to buy in 2022
The attraction of all three biotech stocks is their potential....
December 24, 2022, 10:07 am
Top stocks: egg producer and biotech hit new highs
Top stocks hit new highs. Cal-Maine broke solidly into its buy zone while biotech MannKind reached the ...
December 23, 2022, 4:00 pm
biotech and medical stocks leading performers as 2022 draws to a close
These leading biotech stocks have had a good quarter and some may have room to run, while for others it...
December 23, 2022, 3:49 pm
biotech is set for a blockbuster 2023: here's why
The biotech sector has been outperforming the major U.S. indices for the past few months. Can the stren...
December 23, 2022, 11:17 am
biotech stock finds favor amongst mutual fund managers
A hyper-bullish breakaway gap supports positive price action in this leading biotech stock. The post ...
December 23, 2022, 10:09 am
Cytodyn to hold webcast to discuss the performance of leronlimab in clinical trials and recent charges against former ceo
VANCOUVER, Washington, Dec. 23, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing l...
December 23, 2022, 8:00 am